A detailed history of Cambridge Investment Research Advisors, Inc. transactions in Certara, Inc. stock. As of the latest transaction made, Cambridge Investment Research Advisors, Inc. holds 10,538 shares of CERT stock, worth $115,812. This represents 0.0% of its overall portfolio holdings.

Number of Shares
10,538
Previous 10,238 2.93%
Holding current value
$115,812
Previous $142,000 13.38%
% of portfolio
0.0%
Previous 0.0%

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 28, 2024

BUY
$10.46 - $16.58 $3,138 - $4,973
300 Added 2.93%
10,538 $123,000
Q2 2024

Jul 26, 2024

SELL
$13.36 - $18.94 $4,582 - $6,496
-343 Reduced 3.24%
10,238 $142,000
Q1 2024

Apr 24, 2024

BUY
$15.65 - $19.45 $165,592 - $205,800
10,581 New
10,581 $189,000

Others Institutions Holding CERT

About Certara, Inc.


  • Ticker CERT
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Health Information Services
  • Shares Outstandng 159,899,008
  • Market Cap $1.76B
  • Description
  • Certara, Inc. provides software products and technology-enabled services to customers for biosimulation in drug discovery, preclinical and clinical research, regulatory submissions, and market access. It offers medicines to patients using biosimulation software, technology, and services to transform drug discovery and development. The company al...
More about CERT
Track This Portfolio

Track Cambridge Investment Research Advisors, Inc. Portfolio

Follow Cambridge Investment Research Advisors, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Cambridge Investment Research Advisors, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Cambridge Investment Research Advisors, Inc. with notifications on news.